Peer-reviewed veterinary case report
Survival after doxorubicin chemo for dogs with right atrial masses
By Ghaffari, S et al.·Published in The Journal of small animal practice·2014·Department of Internal Medicine, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A retrospective evaluation of doxorubicin-based chemotherapy for dogs with right atrial masses and pericardial effusion.
- Species:
- dog
Plain-English summary
A dog with a right atrial mass and fluid around the heart (pericardial effusion) was treated with doxorubicin-based chemotherapy. This treatment was the only option given, as the dog had not undergone any surgery. While the dog experienced some mild side effects from the chemotherapy, it was able to survive for an average of about 139 days after starting treatment. This suggests that doxorubicin can be an effective option for dogs facing this serious condition.
People also search for: dog heart mass treatment · doxorubicin for dogs · pericardial effusion in dogs · dog chemotherapy side effects
Abstract
OBJECTIVE: To report the outcome of doxorubicin-based chemotherapy as the sole treatment for dogs with echocardiographically identified right atrial masses and pericardial effusion. METHODS: A retrospective study of case records of dogs with right atrial masses treated with doxorubicin. Dogs were excluded from the study if they had any type of surgery performed such as pericardiectomy or right atrial mass resection, or if their chemotherapy protocol did not include doxorubicin. The data collected included signalment, history, physical examination findings, diagnostic test results and long-term survival. RESULTS: Dogs with right atrial masses and pericardial effusion that received doxorubicin-based chemotherapy alone had a median survival of 139 · 5 days (range 2 to 302 days). Chemotherapy side effects were frequent but mild. CLINICAL SIGNIFICANCE: Doxorubicin-based chemotherapy alone appears to be a viable treatment option for dogs with echocardiographically identified right atrial masses and pericardial effusion.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/24697499/